DCF Advisers’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,090
| Closed | -$156K | – | 70 |
|
|
2021
Q4 | $156K | Hold |
3,090
| – | – | 0.06% | 64 |
|
|
2021
Q3 | $201K | Sell |
3,090
-4,629
| -60% | -$301K | 0.09% | 69 |
|
|
2021
Q2 | $299K | Sell |
7,719
-281
| -4% | -$10.9K | 0.11% | 71 |
|
|
2021
Q1 | $420K | Buy |
8,000
+1,894
| +31% | +$99.4K | 0.18% | 66 |
|
|
2020
Q4 | $415K | Sell |
6,106
-4,930
| -45% | -$335K | 0.17% | 63 |
|
|
2020
Q3 | $423K | Sell |
11,036
-240
| -2% | -$9.2K | 0.22% | 56 |
|
|
2020
Q2 | $436K | Sell |
11,276
-1,124
| -9% | -$43.5K | 0.24% | 49 |
|
|
2020
Q1 | $372K | Buy |
12,400
+6,920
| +126% | +$208K | 0.24% | 48 |
|
|
2019
Q4 | $622K | Buy |
+5,480
| New | +$622K | 0.39% | 35 |
|